Dali Pharmaceuticalco.Ltd Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 3/6
Dali Pharmaceuticalco.Ltd has a total shareholder equity of CN¥361.4M and total debt of CN¥19.3M, which brings its debt-to-equity ratio to 5.4%. Its total assets and total liabilities are CN¥450.2M and CN¥88.8M respectively.
Anahtar bilgiler
5.4%
Borç/özkaynak oranı
CN¥19.34m
Borç
Faiz karşılama oranı | n/a |
Nakit | CN¥207.69m |
Eşitlik | CN¥361.39m |
Toplam yükümlülükler | CN¥88.81m |
Toplam varlıklar | CN¥450.20m |
Son finansal sağlık güncellemeleri
Güncelleme yok
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 603963's short term assets (CN¥273.3M) exceed its short term liabilities (CN¥77.3M).
Uzun Vadeli Yükümlülükler: 603963's short term assets (CN¥273.3M) exceed its long term liabilities (CN¥11.5M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 603963 has more cash than its total debt.
Borcun Azaltılması: 603963's debt to equity ratio has increased from 0% to 5.4% over the past 5 years.
Borç Kapsamı: 603963's operating cash flow is negative, therefore debt is not well covered.
Faiz Kapsamı: Insufficient data to determine if 603963's interest payments on its debt are well covered by EBIT.